aibioRegen Biopharma files Form 15 for common and Series A preferred stock
Tickers RGBP
The notice lists 482 holders of record of common stock and 480 of Series A preferred stock. It relies on Rule 12h-3(b)(1)(ii).
Key facts
- Company
- Regen Biopharma, Inc. (OTC: RGBP)
- News type
- Listings
- Primary source
- Regen Biopharma, Inc. 15-15D (2024-12-26)
Regen Biopharma, Inc. filed a Form 15 with the Securities and Exchange Commission covering its Common Stock and its Series A Preferred Stock. Form 15 is a certification and notice of termination of registration of a class of securities, or suspension of the duty to file reports under the Securities Exchange Act of 1934.
The company marked Rule 12h-3(b)(1)(ii) as the provision it relies on to terminate or suspend the duty to file reports. The filing lists no other class of securities for which a duty to file reports remains.
The notice gives the approximate number of holders of record as 482 for the common stock and 480 for the Series A Preferred Stock.
The company's principal executive offices are in La Mesa, California, and its Commission File Number is 333-191725. Once the duty to file reports ends, the company would no longer be required to file periodic reports such as annual and quarterly reports with the SEC.